CrushSCI.com
Journal Selection & Manuscript Polishing Services
ANNALS OF HEMATOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

ANNALS OF HEMATOLOGY

Springer SCIE Non-OA
2026 Emerging Zone 42025 CAS Zone 32025 JCR Q2
176.8Average days
111Median days
57Fastest days
526Longest days
5672025 publications

Paper Review Records

All Paper Review Records

12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

86 days

Global burden of acute lymphoblastic leukemia following the COVID-19 pandemic

AuthorsHongxuan Fan; Yafen Yang; Yanyan Lu; Jiahui Li; Zhuolin Huang; Zhaoyu Ren; Boda Zhou

Affiliations1. Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China; 2. Department of Cardiology, Second Hospital of Shanxi Medical University, Taiyuan, China; 3. Department of Haematology, Second Hospital of Shanxi Medical University, Taiyuan, China

Source PDF DOI Publisher page
394 days

Mesenchymal stem cells for the adjunctive treatment of cytomegalovirus pneumonia in hematopoietic stem cell transplant recipients: a Single-center prospective study

AuthorsXianghui Liu; Xin Xia; Lingyun Bian; Zaihong Shen; Kun Zhou; Liping Wan; Xianmin Song; Yin Tong

Affiliations1. Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 2. Department of Hematology, Taizhou First People’s Hospital, Huangyan Hospital of Wenzhou Medical University, Taizhou City, China

Source PDF DOI Publisher page
109 days

Clinical profile and treatment outcomes in paediatric and adult acute promyelocytic leukemia: experience from a tertiary care centre in Northern India

AuthorsHarshal Mamlekar; Nandhini Gangadaran; Sanjeev Yadav; Rajesh Kashyap; Khaliqur Rahman; Ruchi Gupta; Manish Singh; Dinesh Chandra; Mona Vijayaran; Prisha Nankana

Affiliations1. Department of Hematology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

Source PDF DOI Publisher page
113 days

Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis

AuthorsErika Morsia; Paola Ranalli; Stefano Baldoni; Stefania. Mancini; Sonia Morè; Chiara Cantò; Dorela Lame; Gaetano La Barba; Antonella Poloni; Serena Rupoli; Mauro Di Ianni

Affiliations1. Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, Ancona, Italy; 2. Hematology Clinic, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy; 3. Department of Medicine and Aging Sciences, University “G. D’Annunzio” of Chieti- Pescara, Pescara, Italy; 4. Hematology Unit, S. Spirito Hospital, Pescara, Italy

Source PDF DOI Publisher page
146 days

Severity patterns and predictors of sickle cell anaemia among Gambian children: A cross-sectional analysis

AuthorsLamin Makalo; Muhammed Manka; Orlianys Ruiz Perez; Sheikh Joof; Fatoumatta Jitteh; Musa Touray; Cessare Medri

Affiliations1. School of Medicine and Allied Health Sciences, Banjul, The Gambia; 2. Department of Paediatrics, Edward Francis Small Teaching Hospital, Banjul, The Gambia

Source PDF DOI Publisher page
57 days

Efficacy of radiotherapy in primary mediastinal diffuse large B-cell lymphoma: a systematic review and meta-analysis of 1,392 patients

AuthorsDongyu Zhuang; Silan Huang; Peng Zhang; Dexin Lei; Yanlou Wang; Honglian Liu; Man Nie; Yi Xia

Affiliations1. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China

Source PDF DOI Publisher page
71 days

Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013–2022 in Finland

AuthorsJuha Ranti; Sanaz Jamalzadeh; Eleonora Mäkelä; Johanna Vikkula; Essi Havula; Sari Luopajärvi; Vesa Lindström

Affiliations1. Department of Hematology, Turku University Hospital, Wellbeing Services County of Southwest Finland, Turku, Finland; 2. Medaffcon Oy, Espoo, Finland; 3. Janssen-Cilag Oy, Espoo, Finland; 4. Department of Hematology, Tampere University Hospital, The Wellbeing Services County of Pirkanmaa, Tampere, Finland; 5. Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland

Source PDF DOI Publisher page
82 days

T-cell acute lymphoblastic leukemia: therapeutic outcomes in adolescents and young adults

AuthorsEmna Azza; Aya Ben Othmen; Maroua Bahri; Roua Hsasna; Raihane Ben Lakhel; Yosr Ben Abdennebi; Lamia Aissaoui

Affiliations1. Pediatric Hematology Department, Aziza Othmana Hospital, Tunis, Tunisia; 2. Adult Clinical Hematology Department, Aziza Othmana Hospital, Tunis, Tunisia

Source PDF DOI Publisher page
273 days

Survival analysis and prognosis model construction of elderly patients with acute promyelocyticleukemia: a retrospective study based on SEER database

AuthorsJinhong Jiang; Yonghua Liu; Yuxiao Zeng; Yifen Lan; Bingmu Fang

Affiliations1. Department of Hematology, The Sixth Hospital Affiliated to Wenzhou Medical University, Wenzhou, China

Source PDF DOI Publisher page
85 days

Expanding the frontier of CAR therapy: comparative insights into CAR-T, CAR-NK, CAR-M, and CAR-DC approaches

AuthorsYiling Zhang; Rong Hu; Xiaoling Xie; Yuhua Li

Affiliations1. The Second School of Clinical Medicine, Southern Medical University, Guangzhou, P. R. China; 2. Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, P. R. China; 3. Guangdong Engineering Research Center of Precision Immune Cell Therapy Technology, Guangzhou, P. R. China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.